{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:57:56Z","timestamp":1770447476781,"version":"3.49.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","funder":[{"name":"Red Tem\u00e1tica Cooperativa de Grupos de Investigaci\u00f3n en Sida (RIS) del Fondo de Investigaci\u00f3n Sanitaria (FIS)","award":["SAF2012\u201339075"],"award-info":[{"award-number":["SAF2012\u201339075"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1093\/jac\/dkw049","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T01:29:49Z","timestamp":1458350989000},"page":"1987-1993","source":"Crossref","is-referenced-by-count":19,"title":["A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection"],"prefix":"10.1093","volume":"71","author":[{"given":"Lorna","family":"Leal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexy","family":"Inciarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanza","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Mallolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Laguno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mart\u00ednez-Rebollar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gonz\u00e1lez-Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Manzardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Pich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan A.","family":"Arnaiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Gatell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"key":"2016060709374325000_71.7.1987.1","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"2016060709374325000_71.7.1987.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530280026018"},{"key":"2016060709374325000_71.7.1987.3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with Zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"2016060709374325000_71.7.1987.4","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318162afcb"},{"key":"2016060709374325000_71.7.1987.5","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000301"},{"key":"2016060709374325000_71.7.1987.6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3851\/IMP1955","article-title":"Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir\/ritonavir versus atazanavir each with zidovudine\/lamivudine","volume":"17","author":"Diaz-Brito","year":"2012","journal-title":"Antivir Ther"},{"key":"2016060709374325000_71.7.1987.7","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/QAD.0b013e32833dfad1","article-title":"Tolerability of HIV postexposure prophylaxis with tenofovir\/emtricitabine and lopinavir\/ritonavir tablet formulation","volume":"24","author":"Tosini","year":"2010","journal-title":"AIDS"},{"key":"2016060709374325000_71.7.1987.8","unstructured":"WHO. Post-exposure Prophylaxis to Prevent HIV Infection: Joint WHO\/ILO Guidelines on Post-exposure Prophylaxis (PEP) to Prevent HIV Infection . 2007. http:\/\/www.who.int\/hiv\/topics\/prophylaxis ."},{"key":"2016060709374325000_71.7.1987.9","unstructured":"European AIDS Clinical Society (EACS). Gu\u00edas cl\u00ednicas . 2014. http:\/\/www.eacsociety.org\/files\/guidlines-7.1-spanish.pdf ."},{"issue":"(RR2)","key":"2016060709374325000_71.7.1987.10","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States","volume":"54","author":"Smith","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"2016060709374325000_71.7.1987.11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/135965350000500303","article-title":"HAART tolerability: postexposure prophylaxis in health care workers versus treatment in HIV-infected patients","volume":"5","author":"Quirino","year":"2000","journal-title":"Antivir Ther"},{"key":"2016060709374325000_71.7.1987.12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ139"},{"key":"2016060709374325000_71.7.1987.13","unstructured":"WHO. Guidelines on Post-exposure Prophylaxis for HIV and the Use of Co-trimoxazole Prophylaxis for HIV-related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach . 2015. http:\/\/www.who.int\/hiv\/topics\/prophylaxis ."},{"key":"2016060709374325000_71.7.1987.14","doi-asserted-by":"publisher","DOI":"10.1086\/672271"},{"key":"2016060709374325000_71.7.1987.15","unstructured":"Gesida. Documento de Consenso sobre Profilaxis postexposici\u00f3n ocupacional y no ocupacional en relaci\u00f3n con el VIH, VHB y VHC en adultos y ni\u00f1os . 2015. http:\/\/www.gesida-seimc.org\/guias_clinicas.php ."},{"key":"2016060709374325000_71.7.1987.16","unstructured":"Expert Advisory Group on AIDS (EAGA). Change to Recommended Regimen for Post-exposure Prophylaxis . https:\/\/www.gov.uk ."},{"key":"2016060709374325000_71.7.1987.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-005X(02)72826-7"},{"key":"2016060709374325000_71.7.1987.18","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200203080-00012"},{"key":"2016060709374325000_71.7.1987.19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.12.1376"},{"key":"2016060709374325000_71.7.1987.20","doi-asserted-by":"publisher","DOI":"10.1310\/0Q8A-DFPR-6RV7-HX10"},{"key":"2016060709374325000_71.7.1987.21","unstructured":"WHO. A Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines . Geneva: WHO Press, 2009."},{"key":"2016060709374325000_71.7.1987.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw048"},{"key":"2016060709374325000_71.7.1987.23","doi-asserted-by":"publisher","DOI":"10.1086\/320166"},{"key":"2016060709374325000_71.7.1987.24","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31824a03b8"},{"key":"2016060709374325000_71.7.1987.25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000505"},{"key":"2016060709374325000_71.7.1987.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70181-5"},{"key":"2016060709374325000_71.7.1987.27","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12297"},{"key":"2016060709374325000_71.7.1987.28","doi-asserted-by":"publisher","DOI":"10.1086\/426589"},{"key":"2016060709374325000_71.7.1987.29","doi-asserted-by":"publisher","DOI":"10.1086\/497268"},{"key":"2016060709374325000_71.7.1987.30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ511"},{"key":"2016060709374325000_71.7.1987.31","doi-asserted-by":"publisher","DOI":"10.1086\/518349"},{"key":"2016060709374325000_71.7.1987.32","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050371"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/7\/1987\/11280740\/dkw049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T17:18:28Z","timestamp":1655313508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,6,7]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1093\/jac\/dkw049"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw049","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]}}}